对RAS抑制剂耐药性的另一面
Michelangelo Marasco1, Sandra Misale2
1Catholic University of the Sacred Heart and Fondazione Policlinico Universitario A. Gemelli-IRCCS, Rome, Italy.
Cancer discovery
|November 1, 2024
概括
非遗传机制和细胞可塑性是胰腺癌和肺癌中抗RAS抑制剂的关键. 理解这些因素对于开发有效的癌症疗法至关重要.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 拉斯抑制剂是针对由拉斯突变驱动的癌症的向疗法的关键类别.
- 对RAS抑制剂的耐药性仍然是一个重要的临床挑战,限制了治疗疗效.
- 非遗传机制和细胞可塑性越来越多地被认为是治疗耐药性的驱动因素.
研究的目的:
- 突出非遗传机制在调解抗RAS抑制剂耐药性的关键作用.
- 探索细胞可塑性对胰腺管道腺癌和非小细胞肺癌中获得的耐药性的贡献.
- 为了解决RAS突变癌症中治疗耐药性的问题提供见解.
主要方法:
- 关于非遗传性耐药机制的最新发现的审查和综合.
- 分析细胞可塑性作为获得性抵抗的驱动因素.
- 专注于胰腺管道腺癌和非小细胞肺癌模型.
主要成果:
- 非遗传机制,如表观遗传改变和信号通路重新连接,对RAS抑制剂耐药性有显著的贡献.
- 细胞可塑性允许癌细胞在RAS抑制剂治疗下适应和生存,从而导致获得耐药性.
- 这些机制在胰腺管腺癌和非小细胞肺癌中都很明显.
结论:
- 非遗传因素和细胞可塑性对抗RAS抑制剂的耐药性发展至关重要.
- 针对这些非遗传机制和了解细胞可塑性对于改善治疗策略至关重要.
- 需要进一步的研究来开发能够克服RAS驱动癌症抗性的组合疗法.
更多相关视频
09:38Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
7.9K
07:42Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
7.9K
相关概念视频
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Rous Sarcoma Virus (RSV) and Cancer
5.0K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.0K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
